INNOVATION

Anti-inflammatory product order boost for MGC

PERTH: Trailblazing bio-pharma company MGC Pharmaceuticals, who specialises in the development and production of phytocannabinoid-derived read more

Singular builds reconstructive surgery 3D capability

PERTH: Singular Health has moved to strengthen its suite of medical imaging products by entering read more

FDA approves self-injectable formulation of Xolair

SEATTLE: The FDA has approved a self-injectable formulation of Xolair for appropriate patients with moderate read more

Dedalus says ICS future requires open health eco-system

FLORENCE: On 1 April Dedalus completed its £350million acquisition of DXC Healthcare from DXC Technology, read more